FDA GLP1

"The US Food and Drug Administration (FDA) has instructed all GLP-1 drug-makers to update their warning labels to include the risk of serious kidney injury that can result from dehydration."https://newatlas.com/disease/obesity/kidney-warning-glp1/?utm_source=New+Atlas+Subscribers&utm_campaign=b5bcb947bc-EMAIL_CAMPAIGN_2025_07_24_11_39&utm_medium=email&utm_term=0_65b67362bd-b5bcb947bc-93027845